ADMA Biologics: Strong Product Mix, Growing Margins And Compelling Upside

ADMA Biologics (NASDAQ: ADMA ) is a vertically integrated U.S. Immune Globulin (referred to as IG) plasma manufacturer whose earnings are growing due to two main factors that it directly controls: higher finished-goods yield from each liter of plasma and a mix shiftMy career in the world of investing began at an early age, fueled by the potential for profits, I first began investing at the age of 11 with the help of my father. I first began picking stocks by looking at what was going to logically make money ...